Selecta Biosciences
(NASDAQ) SELB
This security has been delisted. This page is retained for historical reference.
SELB News
3 Top Healthcare Stocks Under $5
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowSELB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
-86%
Return on Equity
2%
Return on Capital
0%
Return on Assets
-53%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$73.94M
Capital Expenditure
$5.45M
Free Cash Flow
$79.39M
Cash & ST Invst.
$125.14M
Total Debt
$12.68M
Selecta Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$78.00K
-92.9%
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
64
N/A
Net Income
$39.18M
-121.2%
EBITDA
$0.00
N/A
Quarterly Fundamentals
Net Cash
$106.79M
-35.8%
Accounts Receivable
$261.00K
-85.2%
Inventory
$0.00
N/A
Long Term Debt
$7.67M
-26.0%
Short Term Debt
$4.19M
+13.0%
Return on Assets
-52.63%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$22.16M
+8.4%
Operating Cash Flow
$22.14M
+4.2%